Louise Færch

1.4k total citations · 1 hit paper
16 papers, 930 citations indexed

About

Louise Færch is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Louise Færch has authored 16 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Louise Færch's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Louise Færch is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Louise Færch collaborates with scholars based in Denmark, United Kingdom and Japan. Louise Færch's co-authors include Ole Kleist Jeppesen, Leigh Perreault, Sue D. Pedersen, Arash Pakseresht, Iichiro Shimomura, Adie Viljoen, Thomas A. Wadden, Melanie J. Davies, Ildiko Lingvay and Julio Rosenstock and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Louise Færch

16 papers receiving 908 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

2021 806 citations Melanie J. Davies, Louise Færch et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louise Færch Denmark	7	720	414	279	240	239	16	930
Brandon K. Bergman United States	5	924 1.3×	393 0.9×	397 1.4×	297 1.2×	299 1.3×	12	1.2k
Trine Vang Skjøth Denmark	12	1.1k 1.6×	614 1.5×	384 1.4×	344 1.4×	304 1.3×	23	1.3k
Federico C. Pérez Manghi United Kingdom	3	877 1.2×	375 0.9×	383 1.4×	291 1.2×	283 1.2×	3	1.1k
Santiago Tofé Spain	12	1.0k 1.4×	270 0.7×	482 1.7×	339 1.4×	155 0.6×	43	1.3k
Arash Pakseresht Denmark	7	707 1.0×	499 1.2×	310 1.1×	233 1.0×	257 1.1×	12	975
Sirel Gurbuz United States	5	677 0.9×	430 1.0×	235 0.8×	192 0.8×	341 1.4×	7	921
Tamer Coskun United States	3	566 0.8×	356 0.9×	194 0.7×	157 0.7×	292 1.2×	6	787
Jeffrey Unger United States	9	741 1.0×	168 0.4×	374 1.3×	200 0.8×	95 0.4×	15	855
Louise Vedtofte Denmark	13	554 0.8×	162 0.4×	205 0.7×	248 1.0×	174 0.7×	19	746
Meera Shah United States	16	438 0.6×	114 0.3×	167 0.6×	542 2.3×	376 1.6×	38	1.0k

Countries citing papers authored by Louise Færch

Since Specialization

Citations

This map shows the geographic impact of Louise Færch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Færch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Færch more than expected).

Fields of papers citing papers by Louise Færch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Færch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Færch. The network helps show where Louise Færch may publish in the future.

Co-authorship network of co-authors of Louise Færch

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Færch. A scholar is included among the top collaborators of Louise Færch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Færch. Louise Færch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pedersen‐Bjergaard, Ulrik, Louise Færch, & Birger Thorsteinsson. (2022). The updated Pedersen-Bjergaard method for assessment of awareness of hypoglycaemia in type 1 diabetes.. PubMed. 69(9). 3 indexed citations

Davies, Melanie J., Louise Færch, Ole Kleist Jeppesen, et al.. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 397(10278). 971–984. 806 indexed citations breakdown →

Perreault, Leigh, Melanie J. Davies, Louise Færch, et al.. (2021). 82-OR: Effect of Semaglutide 2.4 mg on Glucose Metabolism and Body Weight in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial. Diabetes. 70(Supplement_1). 1 indexed citations

Davies, Melanie J., Louise Færch, Ole Kleist Jeppesen, et al.. (2021). Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2). Journal of the Endocrine Society. 5(Supplement_1). A10–A11. 2 indexed citations

Lingvay, Ildiko, Louise Færch, Anna Koroleva, et al.. (2021). 83-OR: Influence of Baseline Characteristics on Weight Loss with Semaglutide 2.4 mg in Adults with Overweight/Obesity and Type 2 Diabetes (STEP 2). Diabetes. 70(Supplement_1). 4 indexed citations

Rubino, Domenica, Louise Færch, Robert F. Kushner, et al.. (2021). 84-OR: Semaglutide 2.4 mg Improves Health-Related Quality of Life in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial. Diabetes. 70(Supplement_1). 2 indexed citations

Olsen, Niels Vidiendal, et al.. (2018). Impact of Genetic Polymorphism in the β2-Receptor Gene on Risk of Severe Hypoglycemia in Patients With Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 103(8). 2901–2908. 5 indexed citations

Færch, Louise, et al.. (2016). Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes. Journal of Diabetes Science and Technology. 10(6). 1230–1235. 11 indexed citations

Orozco‐Beltrán, Domingo, et al.. (2016). Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations. International Journal of Clinical Practice. 70(3). 236–243. 4 indexed citations

10.

Schouwenberg, Bas, et al.. (2015). Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus. Diabetic Medicine. 33(1). 77–83. 15 indexed citations

11.

Pedersen‐Bjergaard, Ulrik, et al.. (2014). The Influence of New European Union Driver’s License Legislation on Reporting of Severe Hypoglycemia by Patients With Type 1 Diabetes. Diabetes Care. 38(1). 29–33. 49 indexed citations

12.

Færch, Louise, Birger Thorsteinsson, Lise Tarnow, et al.. (2014). Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. 16(4). 1036–1045. 6 indexed citations

13.

Færch, Louise, Anne‐Sophie Sejling, Maria Lajer, et al.. (2013). ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. 16(2). 374–381. 4 indexed citations

14.

Færch, Louise, Anders Juul, Ulrik Pedersen‐Bjergaard, & Birger Thorsteinsson. (2012). Association of IGF1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus. Endocrine Connections. 1(1). 31–36. 6 indexed citations

15.

Færch, Louise, Ulrik Pedersen‐Bjergaard, & Birger Thorsteinsson. (2011). High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 71(7). 620–624. 11 indexed citations

16.

Hansen, Christian Stevns, Louise Færch, & Peter Lommer Kristensen. (2010). Testing the validity of the Danish urban myth that alcohol can be absorbed through feet: open labelled self experimental study. BMJ. 341(dec14 2). c6812–c6812. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact